欧洲抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型、性质、服务和最终用户
市场调查报告书
商品编码
1592596

欧洲抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型、性质、服务和最终用户

Europe Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type, Nature, Services, and End User

出版日期: | 出版商: The Insight Partners | 英文 94 Pages | 订单完成后即时交付

价格

2022年欧洲抗体发现市值为8,244.4111亿美元,预计2030年将达到1,3294.816亿美元;预计2022年至2030年复合年增长率为6.2%。

癌症发生率上升推动欧洲抗体发现市场

根据全球癌症观察站 (GLOBOCAN) 2020 年发布的估计,全球有 1,930 万癌症病例。到 2030 年 1 月,癌症倖存者人数预计将达到 2,210 万,这主要与人口老化有关。肺癌、乳癌、大肠癌、摄护腺癌和乳癌是最常见的癌症类型。癌症发生率的上升引起了全世界的关注。以下是 2020 年全球报告的常见癌症病例清单。

2020 年全球新癌症病例

先生。

癌症类型

案件数量(百万)

  • 1. 胃
  • 1.09
  • 2. 皮肤(非黑色素瘤)
  • 1.2
  • 3.前列腺
  • 1.41
  • 4.结肠和直肠
  • 1.93
  • 5. 肺
  • 2.21
  • 6. 乳房
  • 2.26

资料来源:世界卫生组织,2020 年 2 月

癌症现在是一种生活方式疾病,常见于饮食习惯不健康和缺乏体能活动的人。经常饮酒和吸烟会增加患癌症的风险。低收入和中等收入国家的慢性传染病可进一步加剧癌症危险因子。癌症发生率的激增表明需要创新的癌症治疗方法。单株抗体是一类有前景的标靶抗癌药物,可增强免疫系统抑制癌细胞活性和消除癌细胞的天然能力。抗体药物偶联物(ADC)在癌症治疗中也显示出有希望的结果。此外,现代生物技术的进步使研究人员和公司能够提供精心设计的新型抗体,为成功治疗各种类型的癌症铺平道路。因此,不同类型癌症发生率的迅速上升促进了抗体发现市场的成长。

欧洲抗体发现市场概况

欧洲抗体发现市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区在全球市场中占有重要份额。由于单株抗体在研发应用、癌症治疗和免疫疾病管理的使用激增,预计未来几年将强劲成长。此外,对患者资料管理系统的需求不断增长、慢性病的流行以及政府实施抗体服务的倡议预计将为法国、义大利和西班牙等国家的抗体发现市场提供成长机会。

欧洲抗体发现市场收入及 2030 年预测(十亿美元)

欧洲抗体发现市场细分

欧洲抗体发现市场按抗体类型、性质、服务、最终用户和国家分类。

根据抗体类型,欧洲抗体发现市场分为单株抗体、多株抗体等。到 2022 年,单株抗体领域将占据欧洲最大的抗体发现市场。

就性质而言,欧洲抗体发现市场分为人类和人源化、嵌合和鼠类。到 2022 年,人类和人源化细分市场将占据欧洲最大的抗体发现市场。

依服务划分,欧洲抗体发现市场分为噬菌体展示、杂交瘤、基因改造动物、单细胞和酵母展示。到 2022 年,噬菌体展示领域将占据欧洲最大的抗体发现市场。

根据最终用户,欧洲抗体发现市场分为製药和生技公司、研究实验室等。到 2022 年,製药和生物技术公司领域将占据欧洲最大的抗体发现市场。

根据国家/地区,欧洲抗体发现市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022 年,德国在欧洲抗体发现市场份额中占据主导地位。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp 和 Biocytogen Pharmaceuticals 北京有限公司是欧洲抗体发现市场上的一些领先公司。

目录

第 1 章:简介

第 2 章:执行摘要

  • 主要见解

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:欧洲抗体发现市场 - 主要市场动态

  • 市场驱动因素
    • 增加研发投资
    • 癌症发生率上升
  • 市场限制
    • 生产成本高
  • 市场机会
    • 发展中地区生物技术产业的扩散
  • 未来趋势
    • 客製化抗体的开发
  • 驱动因素和限制的影响:

第 5 章:抗体发现市场 - 欧洲市场分析

  • 2020-2030 年欧洲抗体发现市场收入

第 6 章:欧洲抗体发现市场分析 - 按抗体类型

  • 概述
  • 单株抗体
  • 多株抗体抗体
  • 其他的

第 7 章:欧洲抗体发现市场分析 - 本质上

  • 概述
  • 人性化与人性化
  • 嵌合体
  • 鼠类

第 8 章:欧洲抗体发现市场分析 - 按服务

  • 概述
  • 噬菌体展示
  • 杂交瘤
  • 基因改造动物
  • 酵母展示
  • 单细胞

第 9 章:欧洲抗体发现市场分析 - 按最终用户

  • 概述
  • 製药和生物技术公司
  • 研究实验室
  • 其他的

第 10 章:欧洲抗体发现市场 - 国家分析

    • 欧洲
      • 英国
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 欧洲其他地区

第 11 章:抗体发现市场-产业格局

  • 概述
  • 抗体发现市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章:公司简介

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd

第 13 章:附录

Product Code: BMIRE00030736

The Europe antibody discovery market was valued at US$ 8,24,441.11 million in 2022 and is expected to reach US$ 13,29,481.60 million by 2030; it is estimated to register a CAGR of 6.2% from 2022 to 2030.

Rising Incidence of Cancer Drives Europe Antibody Discovery Market

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide.

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds up to the risk of developing cancer. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Europe Antibody Discovery Market Overview

The European antibody discovery market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global market. It is expected to register a robust growth rate in the coming years owing to the surging use of monoclonal antibodies in R&D applications, cancer therapies, and immunological disorder management. Further, the rising need for patient data management systems, the prevalence of chronic diseases, and government initiatives for the implementation of antibody services are expected to provide growth opportunities for the antibody discovery market in countries such as France, Italy, and Spain.

Europe Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)

Europe Antibody Discovery Market Segmentation

The Europe antibody discovery market is categorized into antibody type, nature, services, end user, and country.

Based on antibody type, the Europe antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Europe antibody discovery market share in 2022.

In terms of nature, the Europe antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Europe antibody discovery market share in 2022.

By services, the Europe antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Europe antibody discovery market share in 2022.

Based on end user, the Europe antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Europe antibody discovery market share in 2022.

Based on country, the Europe antibody discovery market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe antibody discovery market share in 2022.

Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Europe antibody discovery market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Antibody Discovery Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Investments in Research & Development
    • 4.1.2 Rising Incidence of Cancer
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Production
  • 4.3 Market Opportunities
    • 4.3.1 Proliferation of Biotechnology Industry in Developing Regions
  • 4.4 Future Trends
    • 4.4.1 Developments for Custom Antibodies
  • 4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Europe Market Analysis

  • 5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Europe Antibody Discovery Market Analysis - by Antibody Type

  • 6.1 Overview
  • 6.2 Monoclonal Antibodies
    • 6.2.1 Overview
    • 6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Polyclonal Antibodies
    • 6.3.1 Overview
    • 6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Antibody Discovery Market Analysis - by Nature

  • 7.1 Overview
  • 7.2 Human and Humanized
    • 7.2.1 Overview
    • 7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Chimeric
    • 7.3.1 Overview
    • 7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Murine
    • 7.4.1 Overview
    • 7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis - by Services

  • 8.1 Overview
  • 8.2 Phage Display
    • 8.2.1 Overview
    • 8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Hybridoma
    • 8.3.1 Overview
    • 8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Transgenic Animal
    • 8.4.1 Overview
    • 8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Yeast Display
    • 8.5.1 Overview
    • 8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Single Cell
    • 8.6.1 Overview
    • 8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Pharmaceutical and Biotechnology Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Research Laboratories
    • 9.3.1 Overview
    • 9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Antibody Discovery Market - Country Analysis

  • 10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
    • 10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 UK
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.3 France
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
      • 10.1.1.6 Rest of Europe
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
        • 10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
        • 10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
        • 10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Antibody Discovery Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Charles River Laboratories International Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Creative Biolabs Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Evotec SE
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Sartorius AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Aragen Life Sciences Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Twist Bioscience Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Antibody Discovery Market Segmentation
  • Table 2. New Cancer Cases Worldwide, in 2020
  • Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
  • Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
  • Table 29. Glossary of Terms, Antibody Discovery Market

List Of Figures

  • Figure 1. Europe Antibody Discovery Market Segmentation, by Country
  • Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
  • Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
  • Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
  • Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
  • Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Growth Strategies in the Antibody Discovery Market